Comparative analysis of TARGET and PI-FAB scores in mpMRI surveillance after HIFU therapy for localized prostate cancer

Both scores demonstrated comparable diagnostic performance particularly in excluding in-field clinically significant prostate cancer recurrence post-HIFU and thus may be valuable, non-invasive tools as part of comprehensive monitoring strategies after HIFU treatment. However, challenges in detecting local tumor recurrence after HIFU therapy persist and require further refinement and optimization of the scores.